As an accomplished researcher with over 20 years of experience in biotech, I have delivered clinical assets in autoimmune and oncology indications and supervised antibody engineering campaigns. My expertise lies in therapeutic antibody discovery, antibody generation, protein engineering, and process development of biologics. My track record includes generating novel assets and developing picomolar monoclonal therapeutic IgGs. I have extensive experience in natural human therapeutic antibody discovery, hybridoma technology, and cloning of fully human antibodies. As a former Research Associate at The Scripps Research Institute I have been involved in projects on biological warfare, vaccines, and cancer therapy. My leadership and technical skills have enabled me to manage multiple cross-functional teams and deliver projects on time. I hold a Ph.D. in Pharmaceutical Technology from the University of Frankfurt, Germany and a Bachelors in Pharmaceutics/Biopharmaceutics from the University of Greifswald, Germany.